Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
During weeks 1-2, AOD-9604 begins stimulating lipolysis in adipose tissue
Schedule a consultation at Luxura Med Spa Chicago to explore personalized strategies for metabolic health, performance, and long-term optimization.
It targets and inhibits the activity of an enzyme known as NNMT, which has been linked to a slowdown in metabolism and a reduction in energy production
They work well but differ in how they might suit patients
Common Side Effects Injectable-route safety is undefined: because no study injected AHK-Cu, there is no characterised safety profile for the subcutaneous route a research vial implies local tolerability, systemic exposure and immunogenicity are simply unknown
The compound was developed by the Australian biotech firm Metabolic Pharmaceuticals as a research tool to isolate the lipolytic signaling domain of growth hormone without the receptor-binding region responsible for its anabolic and glucose-handling effects
US$ 23.68
US$ 28.06
US$ 25.11
US$ 23.60
US$ 27.49
